[Hemodynamic and coronary effects of intravenous verapamil in coronary insufficiency]. 1981

M Zygelman, and J P Mérillon, and A Guiomard, and T Eustigneff, and D Zannier, and R Gourgon

Verapamil inhibits calcium influx through the slow calcium canals. The coronary an haemodynamic effects of intravenous Verapamil were studied in 8 patients with chronic coronary insufficiency documented by coronary arteriography. The following measurements were made in spontaneous rhythm and during atrial pacing under basal conditions and 10 minutes after intravenous Verapamil (0.10 to 0.17 mg/kg) relayed with a continuous infusion of 5 x 10(-3) mg/Kg/mn: heart rate, cardiac output, left ventricularr pressure (Millar 5 F micromanometer), femoral artery pressure, coronary sinus flow by continuous thermodilution, oxygen and lactate concentrations in arterial and arterio-venous oxygen difference, and index of myocardial oxygen consumption and the coefficient of lactate extraction were then calculated. The coronary and haemodynamic effects of atrial pacing were similar before and after Verapamil at a given rate. Left ventricula end diastolic pressure decreased, cardiac output and total systemic resistance were unchanged, dP/dt max increased but to a lesser degree after Verapamil (P less than 0.05). Coronary arterio-venous oxygen difference decreased after Verapamil. The coronary and haemodynamic effects of Verapamil were similar in spontaneous rhythm and during atrial pacing. In spontaneous rhythm, the heart rate and left ventricular end diastolic pressure increased. In spontaneous and paced rhythm, femoral artery pressure, total systemic resistance and dP/dt max decreased. Cardiac output remained the same. Myocardial oxygen consumption decreased mainly because of a reduced coronary arterio-venous oxygen difference and because of unchanged coronary flow in spontaneous rhythm oxygen consumption seems to have a favourable effect on the myocardial energy equilibrium as shown by the increased coefficient of lactate extraction during atrial pacing after Verapamil. This study shows the negative inotropic and arterial vasodilator effects of Verapamil to be responsible for the reduced myocardial oxygen consumption. It also caused coronary artery vasodilation.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006325 Heart Atria The chambers of the heart, to which the BLOOD returns from the circulation. Heart Atrium,Left Atrium,Right Atrium,Atria, Heart,Atrium, Heart,Atrium, Left,Atrium, Right
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

M Zygelman, and J P Mérillon, and A Guiomard, and T Eustigneff, and D Zannier, and R Gourgon
February 1978, Arquivos brasileiros de cardiologia,
M Zygelman, and J P Mérillon, and A Guiomard, and T Eustigneff, and D Zannier, and R Gourgon
April 1979, Arquivos brasileiros de cardiologia,
M Zygelman, and J P Mérillon, and A Guiomard, and T Eustigneff, and D Zannier, and R Gourgon
January 1988, Revista espanola de cardiologia,
M Zygelman, and J P Mérillon, and A Guiomard, and T Eustigneff, and D Zannier, and R Gourgon
April 1982, Circulation,
M Zygelman, and J P Mérillon, and A Guiomard, and T Eustigneff, and D Zannier, and R Gourgon
January 1983, Circulation,
M Zygelman, and J P Mérillon, and A Guiomard, and T Eustigneff, and D Zannier, and R Gourgon
December 1986, The American journal of cardiology,
M Zygelman, and J P Mérillon, and A Guiomard, and T Eustigneff, and D Zannier, and R Gourgon
January 1984, American heart journal,
M Zygelman, and J P Mérillon, and A Guiomard, and T Eustigneff, and D Zannier, and R Gourgon
April 1982, The American journal of cardiology,
M Zygelman, and J P Mérillon, and A Guiomard, and T Eustigneff, and D Zannier, and R Gourgon
January 1981, Therapie,
M Zygelman, and J P Mérillon, and A Guiomard, and T Eustigneff, and D Zannier, and R Gourgon
February 1977, Arquivos brasileiros de cardiologia,
Copied contents to your clipboard!